NLRP1 and melanoma: However, despite upregulated MGMT expression, the resistant mechanism was independent of MGMT, and the cells that acquired TMZ resistance showed increased NLRP1 inflammasome activation, NF-κB activity, and IL-1β secretion, which contributed to the melanoma cells’ resistance to TMZ.